Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Vertebrate Genomes Project Phase I: A global reference genome resource.

bioRxiv : the preprint server for biology·2026
Same author

Challenges in predicting chromatin accessibility differences between species.

NAR genomics and bioinformatics·2026
Same author

Local control of dopamine release in nucleus accumbens gates opioid withdrawal aversion.

bioRxiv : the preprint server for biology·2026
Same author

Effect of Anti-Cyclic Citrullinated Peptide Antibody Serostatus on Outcomes of Silicone Metacarpophalangeal Arthroplasty in Patients With Rheumatoid Arthritis.

Hand (New York, N.Y.)·2026
Same author

Neural correlates of combinatorial reasoning in prefrontal cortex.

bioRxiv : the preprint server for biology·2026
Same author

Tegmental kappa-opioid receptor neurons modulate opioid withdrawal via the periaqueductal gray.

Brain : a journal of neurology·2026

Related Experiment Video

Updated: Jun 30, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Fine-mapping candidate neuropsychiatric regulatory variants using cell type-aware comparative genomics.

BaDoi N Phan1,2, Alyssa J Lawler3,4, Jing He5

  • 1Computational Biology Department, School of Computer Science, Carnegie Mellon University; Pittsburgh, PA, USA.

Biorxiv : the Preprint Server for Biology
|June 29, 2026
PubMed
Summary

We developed a new toolkit to find genetic variants linked to diseases by analyzing conserved regulatory DNA across species. This approach improves the identification of functional genomic regions, aiding in understanding disease mechanisms.

More Related Videos

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Related Experiment Videos

Last Updated: Jun 30, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Area of Science:

  • Genomics
  • Computational Biology
  • Evolutionary Biology

Background:

  • Identifying functional genomic loci often relies on sequence conservation, but this fails when regulatory function is maintained despite sequence divergence.
  • Regulatory elements can evolve to maintain function across cell types and species, even with significant sequence changes.

Purpose of the Study:

  • To introduce the Cell Type-Aware Conservation Inference Toolkit (CTACIT) for identifying trait-associated regulatory variants.
  • To improve the imputation of regulatory function by integrating sequence conservation with cell type-specific chromatin data.
  • To enhance the prioritization of variants for functional characterization in disease research.

Main Methods:

  • CTACIT integrates sequence conservation scores with multi-species, cell type-specific open chromatin data.
  • The toolkit imputes regulatory function for genomic loci across numerous species.
  • Computational analysis was applied to neuropsychiatric trait loci, comparing CTACIT results with traditional methods.

Main Results:

  • CTACIT identified higher heritability enrichment and more fine-mapped variants in neuropsychiatric loci compared to sequence conservation or human chromatin data alone.
  • In vivo reporter assays validated CTACIT predictions for enhancers near the DRD2 schizophrenia risk locus.
  • The toolkit successfully prioritized variants in regions of conserved regulatory function.

Conclusions:

  • CTACIT effectively integrates genome conservation and multi-species chromatin data to identify functional regulatory variants.
  • The toolkit addresses a key challenge in linking genetic associations to mechanistic understanding of diseases.
  • CTACIT enhances the discovery of trait-associated regulatory variants, particularly for complex diseases.